| William Gregory Hundley, MD | |
|
417 N 11th St, Richmond, VA 23298-5002 | |
| (804) 628-4327 | |
| (804) 828-4670 |
| Full Name | William Gregory Hundley |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 36 Years |
| Location | 417 N 11th St, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194700484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 0101264892 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Riverside Tappahannock Hospital | Tappahannock, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
› Verified 8 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
› Verified 8 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Gregory Hundley, MD Po Box 91734, Richmond, VA 23291-1734 Ph: (804) 358-6100 | William Gregory Hundley, MD 417 N 11th St, Richmond, VA 23298-5002 Ph: (804) 628-4327 |
News Archive
Professor Lynn Fraser told the 21st annual conference of the European Society of Human Reproduction and Embryology today (Wednesday), that her previous research had shown that certain chemicals known to mimic the female sex hormone, oestrogen, could individually affect the correct functioning of mouse sperm, but now her new research showed that when the chemicals were combined they had an even stronger effect.
The U.S. Food and Drug Administration today announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs' prescribing information and Medication Guides, on the risk of developing opportunistic fungal infections. Some patients with invasive fungal infections have died.
OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
› Verified 8 days ago
Dr. Amy Samantha May Paul, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Dept. Of Internal Medicine/geriatric Medicine, Richmond, VA 23298 Phone: 804-254-3500 Fax: 804-254-1616 | |
Dr. Clifton Linwood Parker, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8300 Fulham Drive, Richmond, VA 23227 Phone: 804-264-5901 | |
Dr. Michael A Mistretta, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6600 W Broad St Ste 300, Richmond, VA 23230 Phone: 804-320-4243 Fax: 804-622-0552 | |
Patricia J Sime, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8921 Fax: 804-560-8992 | |
Dr. Katherine Lavan Smallwood, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6900 Forest Ave, Suite 300, Richmond, VA 23230 Phone: 804-346-1515 Fax: 804-270-2888 | |
Walid G. Abou Assi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7605 Forest Ave, Suite 109, Richmond, VA 23229 Phone: 804-285-6390 Fax: 804-285-6393 | |
Dr. Paulina Essah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 719 N 25th St, Richmond, VA 23223 Phone: 804-253-1963 Fax: 804-780-0862 |